Mumbai (Maharashtra) [India], October 26: Genesys International, an advanced digital mapping company in India, is credited with launching digital twin 3D maps of India. The company is actively developing a critical digital geospatial infrastructure for the country.
New Delhi [India], October 26: In its ongoing commitment to raise awareness about critical health issues, Metropolis Healthcare Limited, India's leading diagnostic service provider, is dedicated to empowering individuals with knowledge and awareness when it comes to breast health. In commemo
New Delhi [India], October 21: Genesis Foundation one of the leading NGOs that supports the treatment of underprivileged children born with congenital heart defects is pleased to announce a pivotal partnership with Sri Sathya Sai Sanjeevani Hospital, Palwal. Sri Sathya Sai Sanjeevani Hospita
A multinational team of researchers has found nearly a dozen genes that contribute to calcium buildup in our coronary arteries, which can lead to life-threatening coronary artery disease, which accounts for up to one in every four fatalities in the United States. Doctors may be able to targe
Five lung stem cell variants predominate in the lungs of patients with advanced cystic fibrosis (CF), Wa Xian and Frank McKeon, two nationally renowned experts in cloning and stem cell science from the University of Houston report. These variants are responsible for important CF pathology fe
Expanding newborn screening (NBS) to include detecting genes linked to an increased risk of neurodevelopmental disorders (NDD) will do more harm than good, claimed a recent Paediatrics article.
Scientists investigating Alzheimer's disease (AD) have discovered millions of genetic variations in the genome that contribute to the progression of this progressive neurological illness.
A new study demonstrated the isolation and sequencing of RNA molecules from a Tasmanian tiger specimen kept at room temperature in a museum collection over a century ago.
According to a recent Paediatrics article, expanding newborn screening (NBS) to include identifying genes associated with an elevated risk of neurodevelopmental disorders (NDD) will cause more harm than good. While some experts believe that identifying NDDs in the newborn period would be a
Two new genes have been discovered by Queen Mary University of London researchers that render people with head and neck cancer resistant to chemotherapy. Cancer cells that were previously resistant to chemotherapy can now respond to it by silencing one of these genes.
The new study, which was released in Nature Communications, explains how specific gene mutations cause pancreatic cancer to proliferate uncontrollably by turning on a "super-enhancer" that activates other genes.
Researchers from Queen Mary University of London have identified two new genes that make patients with head and neck cancer resistant to chemotherapy. By suppressing one of these genes, cancer cells that were previously resistant to chemotherapy can now respond to it.